Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Arvinas Inc (ARVN)

Arvinas Inc (ARVN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
As Early-Onset Breast Cancer Cases Soar in North America and EU, Biotech Ramps Up Response Newswire.ca - Tue Apr 30, 9:30AM CDT

/CNW/ -- USA News Group – An alarming rise in early-onset cancers has medical experts very concerned, as cancer cases in younger people are rising sharply. In...

ONCY : 1.1600 (-1.69%)
ICCM : 1.2000 (+7.14%)
ATOS : 1.6100 (+4.55%)
ARVN : 32.33 (+3.09%)
PFE : 28.82 (+1.55%)
ONC.TO : 1.57 (-3.09%)
Biotech Firms Intensify Efforts as Breast Cancer Strikes Younger Patients at Alarming Rate BayStreet.ca - Tue Apr 30, 9:04AM CDT

USA News Group – An alarming rise in early-onset cancers has medical experts very concerned, as cancer cases in younger people are rising sharply. In particular, a surge in cases of breast cancer is...

ONCY : 1.1600 (-1.69%)
ONC.TO : 1.57 (-3.09%)
ICCM : 1.2000 (+7.14%)
ATOS : 1.6100 (+4.55%)
ARVN : 32.33 (+3.09%)
PFE : 28.82 (+1.55%)
How Recent Biotech Breakthroughs Are Changing the Fight Against Breast Cancer BayStreet.ca - Wed Feb 7, 8:06AM CST

USA News Group – More people are getting breast cancer this year. Around 300,000 women and 2,800 men will find out they have it. While 1 out of every 8 women will hear they have breast cancer sometime...

ONCY : 1.1600 (-1.69%)
ONC.TO : 1.57 (-3.09%)
PFE : 28.82 (+1.55%)
ARVN : 32.33 (+3.09%)
OLMA : 9.85 (-3.15%)
AZN : 76.97 (-0.09%)
How Recent Biotech Breakthroughs Are Changing the Fight Against Breast Cancer BayStreet.ca - Thu Dec 7, 2023

USA News Group – More people are getting breast cancer this year. Around 300,000 women and 2,800 men will find out they have it. While 1 out of every 8 women will hear they have breast cancer sometime...

AVRN : 0.0125 (-30.56%)
ONCY : 1.1600 (-1.69%)
ONC.TO : 1.57 (-3.09%)
PFE : 28.82 (+1.55%)
ARVN : 32.33 (+3.09%)
OLMA : 9.85 (-3.15%)
AZN : 76.97 (-0.09%)
Arvinas, Inc. (ARVN) Reports Q1 Loss, Misses Revenue Estimates Zacks - Fri May 5, 2023

Arvinas, Inc. (ARVN) delivered earnings and revenue surprises of -5.48% and 5.88%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

ARVN : 32.33 (+3.09%)
CELU : 3.31 (-9.07%)
Arvinas and Quantum Leap Healthcare Announce Clinical Study to Evaluate Vepdegestrant (ARV-471) in I-SPY-2 Endocrine Optimization Platform (EOP) Clinical Trial PR Newswire - Tue May 2, 2023

/PRNewswire/ -- Arvinas, Inc. (Nasdaq: ARVN) and Quantum Leap Healthcare Collaborative™ today announced that Arvinas' vepdegestrant (ARV-471), a novel PROTAC®...

ARVN : 32.33 (+3.09%)
Harmony Biosciences Holdings, Inc. (HRMY) Surpasses Q1 Earnings and Revenue Estimates Zacks - Tue May 2, 2023

Harmony Biosciences Holdings, Inc. (HRMY) delivered earnings and revenue surprises of 9.09% and 0.78%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the...

HRMY : 29.70 (-0.54%)
ARVN : 32.33 (+3.09%)
Arvinas, Inc. (ARVN) Surges 7.6%: Is This an Indication of Further Gains? Zacks - Fri Apr 14, 2023

Arvinas, Inc. (ARVN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the...

ARVN : 32.33 (+3.09%)
ZLAB : 20.85 (-3.25%)
Arvinas, Inc. (ARVN) Reports Q4 Loss, Misses Revenue Estimates Zacks - Thu Feb 23, 2023

Arvinas, Inc. (ARVN) delivered earnings and revenue surprises of -50% and 8.29%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

ARVN : 32.33 (+3.09%)
ADMA : 9.10 (-0.66%)
Author
3 Small-Cap Biopharma Stocks that Could See Big Growth in 2023 MarketBeat - Fri Jan 13, 2023

Health care stocks are trying to make a comeback and these three small-cap biopharma companies are leading the charge in some ways.

ARVN : 32.33 (+3.09%)
RCKT : 23.66 (+1.20%)
XNCR : 21.29 (+4.57%)

Barchart Exclusives

Grain Markets: Will Global Production Issues Continue to Push Wheat Prices Higher? Barchart - Wed May 15, 6:36PM CDT
In my interview today with Michelle Rook on AgWeb's Markets Now I spoke about the recent move higher in wheat, soybean, and corn prices. I also discussed crude oil, interest rates, and the cattle markets. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot